Gilead Sciences Limited
Reference: GB-PPON-PPDW-8775-RCQV
23
Awards
€643,513,912
Total awarded
Recent awards
- NHS National Generic Pharmaceuticals - Wave 16a
- NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives
- NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.
- NHS Framework Agreement, Branded Medicines for London and South of England
- Anti-Retroviral Drugs
- NHS Framework for the North of England, Branded Medicine
- NHS Framework for Midland & East Branded Medicines, Tranche B & Annual Tranche
- National Procurement for HIV and Preventative Treatments
- NHS London Branded Medicines - Tranche B - September 2023
- NHS Framework Agreement, Branded Medicines for London and South of England
Get alerts for tenders like this
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.